The price of the pill, which has not been announced, will determine how affordable it will be when it becomes available in early 2024.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2023-07-13 12:42:002023-07-13 12:42:00F.D.A. Approves First U.S. Over-the-Counter Birth Control Pill
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.